147 related articles for article (PubMed ID: 33886014)
1. Saliva secretion is reduced in proton pump inhibitor-responsive non-erosive reflux disease patients.
Koeda M; Tanabe T; Kitasako Y; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Kaise M; Iwakiri K
Esophagus; 2021 Oct; 18(4):900-907. PubMed ID: 33886014
[TBL] [Abstract][Full Text] [Related]
2. Stimulated saliva secretion is reduced in proton pump inhibitor-resistant severe reflux esophagitis patients.
Tanabe T; Koeda M; Kitasako Y; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Kaise M; Iwakiri K
Esophagus; 2021 Jul; 18(3):676-683. PubMed ID: 33590389
[TBL] [Abstract][Full Text] [Related]
3. Differences in salivary secretion and epidermal growth factor concentrations in mild reflux esophagitis and non-erosive reflux disease.
Koeda M; Momma E; Tanabe T; Kitasako Y; Hoshikawa Y; Hoshino S; Kawami N; Iwakiri K
Esophagus; 2023 Apr; 20(2):317-324. PubMed ID: 36344779
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitor Treatment Has Little Effects on Secretion of Saliva in Patients with Proton Pump Inhibitor-Responsive Mild Reflux Esophagitis and Non-Erosive Reflux Disease.
Hoshikawa Y; Momma E; Hoshino S; Kawami N; Kitasako Y; Ikeda M; Iwakiri K
Digestion; 2023; 104(3):187-192. PubMed ID: 36580899
[TBL] [Abstract][Full Text] [Related]
5. Saliva secretion is reduced in mild reflux esophagitis patients.
Koeda M; Tanabe T; Kitasako Y; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Kaise M; Iwakiri K
Esophagus; 2022 Apr; 19(2):351-359. PubMed ID: 34536162
[TBL] [Abstract][Full Text] [Related]
6. Among females older than 50 years, saliva secretion is significantly lower in non-erosive reflux disease patients than in healthy controls.
Hoshikawa Y; Momma E; Koeda M; Tanabe T; Hoshino S; Kawami N; Iwakiri K
Esophagus; 2024 Jan; 21(1):76-82. PubMed ID: 37843630
[TBL] [Abstract][Full Text] [Related]
7. Significantly Lower Saliva Secretion in Females With Gastroesophageal Reflux Disease and Healthy Subjects Than in Males.
Momma E; Koeda M; Hoshikawa Y; Tanabe T; Hoshino S; Kawami N; Iwakiri K
Cureus; 2023 May; 15(5):e39020. PubMed ID: 37323355
[TBL] [Abstract][Full Text] [Related]
8. Patients with gastroesophageal reflux disease (both reflux oesophagitis and non-erosive reflux disease): Prevalence and severity of erosive tooth wear and saliva properties.
Kitasako Y; Tanabe T; Koeda M; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Ikeda M; Iwakiri K
J Oral Rehabil; 2024 Feb; 51(2):305-312. PubMed ID: 37727994
[TBL] [Abstract][Full Text] [Related]
9. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
Kusano M; Hosaka H; Kawamura O; Kawada A; Kuribayashi S; Shimoyama Y; Yasuoka H; Mizuide M; Tomizawa T; Sagawa T; Sato K; Yamada M
J Gastroenterol; 2015 Mar; 50(3):298-304. PubMed ID: 24919745
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
[TBL] [Abstract][Full Text] [Related]
11. In females, salivary secretion was significantly lower in patients with severe reflux esophagitis than in healthy controls.
Hoshino S; Momma E; Koeda M; Hoshikawa Y; Tanabe T; Kawami N; Kitasako Y; Iwakiri K
Esophagus; 2024 Jul; 21(3):383-389. PubMed ID: 38536601
[TBL] [Abstract][Full Text] [Related]
12. The effects of proton pump inhibitors on autonomic tone in patients with erosive and non-erosive esophagitis.
Jones EL; Perring S; Khattab A; Allenby-Smith O
Neurogastroenterol Motil; 2016 May; 28(5):659-64. PubMed ID: 26748487
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
[TBL] [Abstract][Full Text] [Related]
14. Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease.
Yandrapu H; Marcinkiewicz M; Poplawski C; Han K; Zbroch T; Goldin G; Sarosiek I; Namiot Z; Sarosiek J
Am J Med Sci; 2015 May; 349(5):385-91. PubMed ID: 25789686
[TBL] [Abstract][Full Text] [Related]
15. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.
Weijenborg PW; Cremonini F; Smout AJ; Bredenoord AJ
Neurogastroenterol Motil; 2012 Aug; 24(8):747-57, e350. PubMed ID: 22309489
[TBL] [Abstract][Full Text] [Related]
16. Saliva Secretion Is Significantly Lower in Female Patients with Mild Reflux Esophagitis than in Female Healthy Controls.
Momma E; Koeda M; Hoshikawa Y; Tanabe T; Hoshino S; Kitasako Y; Kawami N; Iwakiri K
Digestion; 2023; 104(4):299-305. PubMed ID: 36750039
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
Miyamoto M; Manabe N; Haruma K
Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
[TBL] [Abstract][Full Text] [Related]
18. The modified glucose clearance test: a novel non-invasive method for differentiating non-erosive reflux disease and erosive oesophagitis.
Fujinami H; Kudo T; Miyazaki T; Hosokawa A; Mihara H; Ando T; Sugiyama T
Aliment Pharmacol Ther; 2008 Nov; 28(10):1259-64. PubMed ID: 18761705
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
20. [Non-erosive reflux disease (NERD)].
Kasugai K; Funaki Y; Izawa S; Ogasawara N; Sasaki M
Nihon Rinsho; 2016 Aug; 74(8):1351-1356. PubMed ID: 30562441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]